OTC · WNFT
Worldwide NFT Inc.
$0.15+$0.01 (+3.45%)
Worldwide NFT Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.71% below the high.
Loading market information…
OTC · NGRC · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
National Graphite Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.1% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
National Graphite Corp. (NGRC), operating through its subsidiary Biotech Development Corp., functions as a biopharmaceutical enterprise specializing in risk and cost-sharing models. The company establishes partnerships with clinical-stage firms dedicated to developing novel biological entities or innovative therapeutic platforms. These collaborations aim to address a wide spectrum of health conditions, encompassing common illnesses, rare disorders, and those with significant unmet medical requirements. Among its key pipeline developments is ELAFIN, a drug candidate identified as a human-identical protein. ELAFIN is being developed specifically for the management of postoperative inflammatory complications. The advancement of ELAFIN is further supported by a collaboration agreement with Proteo Inc. Founded in 2006, National Graphite Corp. was formerly known as Lucky Boy Silver Corporation until it officially adopted its current name in May 2012. The company maintains its operational headquarters in Duesseldorf, Germany.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 11:27 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.15+$0.01 (+3.45%)
Worldwide NFT Inc.’s quoted price sits in the lower half of its reported 52-week range, 64.71% below the high.
$0.29$0.00 (0.0%)
Arsenal Digital Holdings, Inc.’s quoted price sits in the lower half of its reported 52-week range, 56.72% below the high.
$0.00$0.00 (0.0%)
Plandaí Biotechnology, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.01$0.00 (0.0%)
Broadcast Marketing Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.76% below the high.
$0.00+$0.00 (+3.57%)
AVVAA World Health Care Products, Inc.’s quoted price sits in the upper half of its reported 52-week range, 39.58% below the high.
$0.02$0.00 (0.0%)
Arax Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 95.71% below the high.
$0.00$0.00 (0.0%)
Metavesco, Inc.’s quoted price sits in the lower half of its reported 52-week range, 73.68% below the high.
$0.01$0.00 (0.0%)
Ameriguard Security Services, Inc.’s quoted price sits in the lower half of its reported 52-week range, 79.58% below the high.
